|
|
|
|
|
|
1
|
Molecular Docking of mu-, delta-and kappa-opioid receptors with selected ligands.
|
6
|
Determination of the ligand-receptor complexes and the docking parameters that describe them.
|
|
2
|
Molecular docking of neurotensin receptors with selected ligands.
|
6
|
Determination of the ligand-receptor complexes and the docking parameters that describe them.
|
|
3
|
Molecular docking of cannabinoid receptors with selected ligands.
|
6
|
Determination of the ligand-receptor complexes and the docking parameters that describe them.
|
|
4
|
Development of a mathematical model for predicting the biological activity using the results of the molecular docking of new ligands.
|
9
|
Mathematical model for the prediction of biological activity through the use of the results of the molecular docking of new ligands.
|
|
5
|
Determination of biological activity of the mu-, delta-and kappa-opioid, neurotensin and cannabinoid receptors.
|
3
|
Prediction of biological activity through the use of the created model.
|
|
6
|
Organizing webinars.
|
6
|
Organization of 3 webinars.
|
|
7
|
Creating an interactive platform where results and expertise of the members of the project will be promoted.
|
9
|
Functioning interactive WEB platform.
|
Български
English